Adipokines and Adipocyte Targets in the Future Management of Obesity and the Metabolic Syndrome

Title: Adipokines and Adipocyte Targets in the Future Management of Obesity and the Metabolic Syndrome

Volume: 7 Issue: 1

Author(s): S. Kralisch, M. Bluher, R. Paschke, M. Stumvoll and M. Fasshauer

Affiliation:

Keywords: Adipokine, diabetes mellitus, insulin resistance, obesity

Abstract: The role of adipocytes has been recently better understood. Several adipocytokines have been identified, including leptin, a main regulator of appetite and energy expenditure, adiponectin and others, as novel insulinsensitizers/ insulin-mimetics, and some others inducing insulin resistance. Adipocytokines thus represent interesting novel drug targets in the future management of obesity.

Cite this article as:

Kralisch S., Bluher M., Paschke R., Stumvoll M. and Fasshauer M., Adipokines and Adipocyte Targets in the Future Management of Obesity and the Metabolic Syndrome, Mini-Reviews in Medicinal Chemistry 2007; 7 (1) . https://dx.doi.org/10.2174/138955707779317821